Type: Research Project page: Access page Country: Portugal Synopsis: Portugal’s Biotechnology Industry Organization (P-BIO) is the only association that brings together the vast majority of companies linked to the biotechnology and life sciences sector. Since it was founded in 1999, it has been the cornerstone for development and support of biotechnology in Portugal. P-BIO seeks...
Type: Research Infrastructure PROGRAMME Project page: Access page Country: Portugal Synopsis: iNOVA4Health is a translational medicine programme organizing the efforts of biomedical researchers involved in i) biological understanding of disease, lead compounds and biopharmaceuticals pre-discovery, ii) technological scientists involved in preclinical development, and iii) clinicians involved in early clinical and first-in-man clinical trials from institutions...
Type: Research Project page: Access page Country: Portugal Synopsis: At INL – International Iberian Nanotechnology Laboratory, located in Braga (North of Portugal), scientists and engineers from all over the world work in a highly interdisciplinary environment and strive to make INL become a worldwide hub for the deployment of Nanotechnology,addressing society’s grand challenges. The INL...
Type: Research Project page: Access page Country: Portugal Synopsis: Created in 1991 through a University of Coimbra initiative, Instituto Pedro Nunes (IPN) is a private non-profit organisation which promotes innovation and the transfer of technology, establishing the connection between the scientific and technological environment and the production sector, by acting in three complementary areas: Research...
Dates: 01/01/2021 31/12/2025 Topic: Training Project type: Project target: Neurology Financing: H2020-EU.4.c. – Establishing ERA Chairs Participating agents: CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO Keywords: neurobiology; cell biology; pathology; brain; CNC Countries: Portugal Project page: Access page
Dates: 01/06/2021 31/05/2028 Topic: Procedures Project type: Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: tuberculosis; drug resistance; machine learning; microbiology; simulation software; tool; procedure; clinical trial; biomarker Countries: Netherlands; UK;...
Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...
Dates: 01//02/2020 31/01/2025 Topic: Biomarkers identification Tool Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSIDADE NOVA DE LISBOA Keywords: nanotechnology; cancer; nanohydrogels; platform; tumour; RNA; nano-material Countries: Portugal Project page: Access page
Dates: 01/01/2021 31/12/2024 Topic: Tool Project type: Preclinic Project target: Autoimmune disease Financing: H2020-EU.2.1.2. – INDUSTRIAL LEADERSHIP – Leadership in enabling and industrial technologies Nanotechnologies H2020-EU.2.1.3. – INDUSTRIAL LEADERSHIP – Leadership in enabling and industrial technologies – Advanced materials Other Participating agents: UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO Keywords: organ-on-chip; rhemautoid arthritis;...
Dates: 01/09/2019 31/08/2026 Topic: Tool AI/Big Data Biomarkers identification Project type: Preclinic Clinic Guidelines Project target: Autoimmune disease Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD Keywords: systemic lupus erythematosus; rheumatoid arthritis; multiple sclerosis; asthma;...